Clinical Trials Logo

Ulcerative Colitis in Remission clinical trials

View clinical trials related to Ulcerative Colitis in Remission.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03122613 Terminated - Clinical trials for Ulcerative Colitis in Remission

Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis

Start date: June 19, 2017
Phase: N/A
Study type: Interventional

UC is a chronic inflammatory bowel disorder with relapsing and remitting course. The efficacy of mesalazine in preventing relapse in patients with UC is well-known and supported by randomized studies. However, mesalazine can be associated with side-effects. In addition, drug compliance is suboptimal, especially when disease is not active. Curcumin is a natural phytochemical derived from the Indian spice turmeric. It is widely used, has potent anti-inflammatory, anti-oxidant and anti-tumour properties. The aims of this double-blind, placebo-controlled randomized trial is to assess the efficacy of curcumin in the prevention of relapse in patients with ulcerative colitis (UC).